Depth bar: Due-diligence dossier for Stamped outreach. Estimates marked [~]; directory facts [dir]; unverified claims [!]. Never invent bill numbers, court outcomes, or emails.

1. Company overview & snapshot

Nectar Lifesciences Ltd (Neclife) is a listed cephalosporin API / formulation manufacturer with flagship API manufacturing at Saidpura, Derabassi, Punjab, FDF at Baddi, HP, and a publicly emphasised 12 MW biomass captive (2×6 MW) covering a large share of site power. Stamped’s wedge is captive-vs-grid residual MD on PSPCL, not “install more green MW.” The account is Band A fit but risk-elevated: FY25 losses, inventory write-down, EuGMP inspection observations, CARE rating pressure, and announced slump sale of API/formulation business to Ceph Lifesciences — ownership and pilot timing must be validated carefully.

1.1 Legal identity & corporate structure

Listed NSE/BSE NECLIFE. FY25 directors’ report: revenue ~₹1,908 Cr (ops commentary also ~₹1,670 Cr depending on source basis); PBT loss ₹161.5 Cr driven largely by inventory mark-down (₹127 Cr order). July 2025 board approved BTA/slump sale of API+formulation business for ₹1,270 Cr and menthol segment for ₹20 Cr. Confirm whether Stamped contracts Neclife or successor Ceph Lifesciences and which consumer number survives.

1.2 What they make & where money comes from

Oral & sterile cephalosporin APIs (Units 1–2 Derabassi), formulations Baddi; historical menthol/menthol derivatives (divestment path). Export/regulated market exposure. Therapeutic concentration risk noted by CARE.

1.3 Plants, addresses & footprint

• API Unit I & II: Village Saidpura, Derabassi / Mohali district 140507 — pilot campus with 12 MW captive.
• FDF: Bhatoli Kalan, Baddi 173205 — HPSEBL if piloted separately.
• Other facilities referenced in investor decks historically (Lalru power mention in older PDF — reconfirm). Do not merge Derabassi and Baddi bills.

1.4 Leadership & CRM map

Bikramjit Singh — DGM Engineering, Derabassi (primary champion). Manish Saini — AM Electrical (energy reports; 12 MW plant familiarity). Iqbal Singh — Senior Electrical. Escalation to Works/Plant Head and CFO if budget freeze. Post-slump-sale, re-map champion under buyer entity.

1.5 Recent news (24 months) & timing for Stamped

• Mar 2025: EuGMP joint inspection (EDQM/AEMPS) — 7 observations including 4 critical; CAPA path; stock reaction reported.
• FY25: inventory write-down, large PBT loss; CARE rating watch/negative implications around Q4 delay and weak metrics.
• Jul 2025: business sale announcements. Timing for Stamped: opex only, short kill criteria, engineering-first; avoid multi-year IT or hardware.

2. Energy profile

DISCOM / supply (name early): PSPCL for Derabassi API residual/grid import; HPSEBL for Baddi FDF. Captive biomass cogeneration alters marginal cost — invoice verification still required for grid MD/energy/PF lines.

2.1 Bill band, tariff & demand

Company claims ~85% captive power historically. Residual PSPCL bill may still be material in absolute ₹ if MD spikes when captive is short [~]. Absolute Band A floor is unknown without invoice — qualify early. Ask: contract demand on PSPCL, banking/export arrangements, ToD interaction with captive schedule.

2.2 Generation, fuel & renewables

12 MW NecLife biomass cogeneration (rice husk / multi-feedstock). DG presence (Manish Saini profile cites large DG/alternator work). Boilers (~40 T mentioned in electrical profile context). Solar open-access not the headline — do not invent.

2.3 EnMS, PAT, ISO, BRSR

EHS page emphasises captive clean energy and GHG framing. BRSR not applicable for periods when market-cap threshold missed (AR commentary). ISO 50001 not confirmed in search. Engineering team prepares monthly energy reports — Path A plausible.

2.4 Likely ₹ leak categories (hypothesis)

Captive shortfall coincident with fermenter/reactor/HVAC peaks → PSPCL MD; chiller/AHU idle in API blocks; compressed air; PF on HT motors; DG vs captive dispatch confusion; unnecessary grid draw during overnight holds.

3. Operations, equipment & digital stack

3.1 Process flow & critical loads

API synthesis/fermentation → isolation → drying → packing (sterile blocks high HVAC). Critical: reactors, centrifuges, dryers, HVAC, chillers, WFI, captive power auxiliaries, HT motors.

3.2 Shifts, seasonality, production pattern

Campaign manufacturing; regulatory remediation periods may change utilisation. CAPA may constrain operational flexibility — respect QA.

3.3 Automation, metering, SCADA/EMS/DCS

Pharma DCS/BMS expected; 12 MW plant has its own controls. Path A: incomer + key feeder tags + bill. No PLC writes.

3.4 Capex / tech projects affecting energy

Historic captive project is sunk. Focus residual grid ₹. Any sale transition freezes nontrivial system installs — emphasise 90-day reversible software-only.

4. Stamped Energy fit analysis

4.1 ICP scorecard

Geography/vertical — pass. Scale historically Band A — pass. Bill floor — qualify residual grid. Decision speed — at risk due to sale/rating stress. Data maturity — medium/high engineering.

4.2 Fit score rationale

8/10 process/captive fit; risk flags cut commercial urgency, not technical fit. May become Ceph Lifesciences account.

4.3 Wedge (parser-critical)

The strongest wedge is: map process peaks against 12 MW captive availability so residual PSPCL MD and energy lines are owned in ₹ and verified with evidence — without selling another EMS portal or more MW.

4.4 Objections & competitors

“85% captive already.” → residual MD still on bill. “Budget freeze / sale.” → 90-day kill criteria, opex, optionally defer until buyer clarity. “Regulatory focus.” → zero control writes; QA-safe scheduling only.

4.5 Pilot design

Derabassi HT + captive boundary. Success: one avoided grid MD event with owner + invoice line. Kill: sale freezes vendors, bill below floor, no data access.

5. Before you reach out

5.1 Discovery checklist

• Confirm entity still NECLIFE vs Ceph Lifesciences for pilot contract.
• PSPCL residual vs captive settlement documents.
• Two recent HT bills + captive generation logs.
• Who owns energy KPI pack monthly?
• CAPA constraints on HVAC changes.
• Baddi out of scope unless separate champion.
• Approver for opex spend under rating stress.
• Interval MD data availability.
• DG start philosophy when captive short.
• IT/OT read-only path approval.

5.2 Do not lead with

• Do not lead with dashboards/AI/ESG carbon first.
• Do not pitch solar EPC or captive expansion.
• Do not discuss stock price or “troubled company.”
• Do not invent bill savings from 85% captive claim.

5.3 Opening hooks

“With 12 MW captive, the ₹ question is residual PSPCL MD when the plant is short — we stay read-only and verify with evidence.”

6. Risks, flags, controversies & sources

6.1 Integrity / controversy / regulatory (search explicitly)

1. EuGMP inspection (Mar 2025): 7 observations / 4 critical at Saidpura API; CAPA underway; reinspection path — cite Business Standard / company filing; not a finding of guilt beyond observations.
2. FY25 inventory write-down & PBT loss (~₹161 Cr PBT loss) — disclosed AR/BSE; financing/audit conservatism narrative.
3. CARE rating pressure / watch linked to weak Q4/FY25 and sale uncertainty.
4. Slump sale to Ceph Lifesciences ₹1,270 Cr — continuity risk for champions and contracts.
5. Historical: debt restructuring / share pledging themes in CARE notes — treat as credit context. Search terms also covered NGT/PCB/labour/tax raid — no separate major pollution lawsuit headline located in this pass beyond standard EHS EC compliance postings on site.

6.2 Data quality flags

• Revenue ₹1,670 vs ₹1,908 Cr source basis.
• Post-sale legal entity ambiguity.
• Baddi vs Derabassi DISCOM mix-ups.
• Emails inferred.

6.3 Sources consulted

• neclife.com EHS; BSE AR FY25; CARE PR Jul 2025; Business Standard EuGMP article; LinkedIn engineering staff; Punjab lead report.

Operating diligence addendum (meter → bill → owner)

A1. How to read the first two PSPCL (Derabassi residual) / HPSEBL (Baddi) invoices

Ask the plant to share the latest two HT/EHT invoices with account name unredacted for legal matching, and demand/energy pages intact. Record: sanctioned or contract demand; billing demand; recorded maximum demand; power-factor reading and incentive/penalty line; ToD or peak/off-peak segmentation if present; fuel surcharge / electricity duty / municipal cess; any open-access or captive adjustment; and whether multiple meters roll into one consumer. Photograph or PDF the tariff category. Convert every line that can move with operational behaviour (MD, PF, ToD energy) into a ranked opportunity list — that list is the only list Stamped should sell into on day one.

For Derabassi, the immediate commercial question is whether the consumer that matches the gate address is also the P&L that can approve a 90-day opex pilot. Many North India groups present a trading name on the gate and a different limited-company name on the bill. If they diverge, stop and re-paper the CRM record before proposing Scope of Work language.

A2. Process-specific measurement plan — cephalosporin API + 12 MW biomass captive cogeneration

Build a one-page event dictionary with the electrical owner: which start-up, hold, changeover, CIP, campaign or utility header historically coincides with bill pain. For each event type, ask (a) earliest safe start time, (b) whether the event can stagger versus a peer feeder, (c) what quality/safety interlock forbids delay, and (d) who today gets a WhatsApp if MD warns. Stamped’s value appears only when (d) exists — prescriptions without owners become another unread report.

Interval data preference order: (1) DISCOM 15-minute or AMI pull if available; (2) plant energy-meter logger CSV; (3) DCS/SCADA historian tags for large motors/utility headers; (4) daily energy + production register if interval is impossible. Never claim a percentage saving without production normalisation. Tonnes, batches, pairs, hours of sterile HVAC, or caustic MT are acceptable proxies depending on site.

A3. Path A vs Path B data access

Path A: read-only connection or scheduled export from existing EMS/SCADA/BMS/meter gateway; Stamped never writes setpoints. Path B: weekly CSV drops plus a shared campaign/production calendar. Either path must clear OT/IT security, retention, and need-to-know access. Expect an Indian industrial cyber questionnaire; answer in plain language — software layer, no PLC write, no remote control, bill verification.

If the site already paid for ISO 50001 consultants, VFDs, solar EPCs, or OEM analytics, acknowledge those spend lines explicitly. Stamped should be framed as the closure layer that turns residual observations into assigned rupees and invoice checks — not as a replacement capital project.

A4. 90-Day Bill Verification Program — local framing

Week 0: entity + bill + champion map. Weeks 1–2: baseline MD and energy components with production context. Weeks 3–8: weekly ranked prescription cards (max 5) with owner, due date, expected rupee line, and operational constraint. Weeks 9–12: reconcile executed cards to PSPCL (Derabassi residual) / HPSEBL (Baddi) invoice components; document kill or expand. Commercial Band A working fee Rs 2–5 lakh [~] fixed for the proof — present as structured verification, not a discount pilot. Kill criteria: bill below ICP floor; no accessible data; no plant owner; unstable production without usable normalisation; zero controllable lever after two review cycles.

A5. Cluster and reference context

Field sequencing for this campaign batch should respect peer density: Mandi Gobindgarh steel day; Derabassi–Baddi–Rajpura chemistry day; Ghaziabad–Muzaffarnagar steel day; Kanpur–Unnao leather/packaging day. Peer references are for routing confidence, never for inventing shared bills. Keep each legal entity’s invoice private.

A6. Safety, quality and integrity boundaries

No outreach message may imply Stamped will change validated recipes, membrane current density, Tempcore quench parameters, sterile differential pressures, or tannery finish formulas. Those domains stay with process owners; Stamped only sequences and attributes cost to events inside already-approved envelopes. Controversies, historical tax matters, rating actions or inspections are pre-call awareness — they are not cold-call openers.

Contract continuity: re-check Ceph Lifesciences slump-sale closing before SOW.

Extended call-prep narrative (Stamped field use)

B1. First 20 minutes of discovery

Open with process respect, not software. Confirm legal entity on the invoice, DISCOM name, and who owns the largest feeder MD event in the last 90 days. Ask for two invoices and one production calendar export before any platform demo. If the champion cannot produce bills within a week, treat the opportunity as stalled — Bill Verification Program without invoices is theatre. Record whether Path A (historian/meter export) or Path B (CSV) is realistic given OT policy. Confirm the economic buyer who can approve a Rs 2–5 lakh [~] fixed 90-day fee without a full ERP tender.

B2. Prescription card discipline

Every recommendation must name: event, owner, due date, expected rupee line on the DISCOM invoice, operational constraint, and evidence of execution. Cards without owners are deleted. Cap weekly cards at five so plant teams are not flooded. Prefer MD sequencing and idle-hold cuts before exotic tariff products. Never propose changing validated recipe, membrane current, sterile pressure, or Tempcore quench parameters. If quality or safety forbids a schedule change, mark the lever as blocked and move on — credibility beats aggressive savings claims.

B3. Verifying savings without gaming

A lower bill alone is not success if tonnes, pairs, or batches fell. Normalise against a production proxy agreed in week 1. Document holidays, forced outages, new-line commissioning, captive/solar settlement changes, and weather-sensitive HVAC. Keep a decision ledger shared with the plant: recommendation, owner, status, expected vs observed invoice delta. Present kill or expand at day 90 with the same ledger — this is how Stamped differs from audit PDFs that never close.

B4. Competitive and incumbent handling

If the site has EMS/SCADA/BMS, OEM analytics, ISO consultants, or solar EPCs, congratulate the spend and ask what residual bill lines still surprise them monthly. Position Stamped as the closure layer: rupee assignments and invoice reconciliation. Refuse head-to-head dashboard bake-offs. If Gujarat, Panipat, or Noida corporate IT appears, keep plant electrical as the proof owner and let corporate rubber-stamp after a verified bill line — not before.

B5. Geographic and cluster logistics

Batch 3 spans Mandi Gobindgarh, Paonta/Derabassi/Rajpura, Ghaziabad/Muzaffarnagar, and Kanpur–Unnao. Plan field days by corridor. Carry printed one-pagers: Fit score, DISCOM hypothesis, strongest wedge sentence, and two discovery questions. After each visit, update extras field intel — especially corrected phones, electrical names, and whether the bill cleared Rs 30 lakh/month.

B6. Messaging hygiene for this batch

Owner-operated steel/leather accounts tolerate Hindi-friendly WhatsApp and short calls. Listed pharma/chemical accounts prefer email plus LinkedIn with technical depth. Never open with controversies (GST/Excise history, EuGMP observations, rating actions) — those are internal briefings only. Always name DISCOM early in research-backed prep sheets so call-prep UI can render correctly.

6.4 Evidence discipline and next research actions

This dossier separates three evidence classes. Verified public facts come from corporate websites, MCA aggregators, annual/BRSR filings, rating rationales, court databases and named LinkedIn profiles. Directional operating hypotheses use disclosed process profiles to decide what to check on the first call; they are not allegations of failure. Commercial estimates—especially monthly electricity spend—remain labelled [~] until the site provides a current HT invoice and production context.

Immediate sequence after first contact: (1) verify legal entity and invoice ownership; (2) collect two DISCOM invoices and document tariff, demand and PF lines; (3) identify the top three load events with the electrical/utility owner; (4) map production or quality constraints that cannot move; (5) agree the smallest controllable boundary for a 90-day trial. Security and governance: confirm permitted interface (historian export, meter CSV, secure file exchange) plus retention and OT approvals. No proposal implies PLC/DCS writes, recipe changes or unapproved remote control.

Treat adverse information proportionately. A negative search is not clearance that no legal, environmental, labour or financial issue exists. When a named proceeding exists, cite source, date, procedural status and exact entity; do not imply guilt or current business impact without reliable evidence. Re-check material sources and contact tenure immediately before a campaign send.